Your browser doesn't support javascript.
loading
Mutational spectrum and genotype-phenotype correlation in Mexican patients with infantile-onset and late-onset Pompe disease.
Martinez-Montoya, Valentina; Sánchez-Sánchez, Luz María; Sandoval-Pacheco, Roberto; Castro, Diana Mónica Anaya; Arellano-Valdez, Carmen Araceli; Ávila-Rejón, Carmen Amor; Aguilar-Juárez, Pedro Alejandro; Espino-Pluma, Martín; González-Santillanes, Cruz Antonio; Martínez-Segovia, Rosa Isela; Olmos-Morfin, Dorian; la Torre, Ofelia Padilla-De; Solís-Sánchez, Ishar; Espinosa, Mónica Vázquez-Del Mercado; Villarroel-Cortés, Camilo Ernesto; Velarde-Félix, Jesús Salvador; López-Valdez, Jaime; Olaiz-Urbina, Julio; Ricárdez-Marcial, Edgar; Vergara-Sánchez, Imelda; Radillo-Díaz, Pablo; Kazakova, Ekaterina; De la Fuente-Cortez, Beatriz; Del Carmen Marquez-Quiróz, Luz; Torres-Octavo, Benjamín; Diaz-Martinez, Rubicel.
Affiliation
  • Martinez-Montoya V; Instituto de Oftalmología Conde ABC Santa Fe, Mexico City, Mexico.
  • Sánchez-Sánchez LM; Genetics Service, Instituto Médico de la Visión, Mexico City, Mexico.
  • Sandoval-Pacheco R; Pediatrics Service, Hospital de Especialidades UMAE 25, Instituto Mexicano del Seguro Social (IMSS), Monterrey, Nuevo León, Mexico.
  • Castro DMA; Pediatrics Emergency Service, Hospital Central Militar de Secretaría de la Defensa Nacional, Mexico City, Mexico.
  • Arellano-Valdez CA; Neurology Service, Hospital General "Dr. Ernesto Ramos Bours", Secretaría de Salud Pública, Hermosillo, Sonora, Mexico.
  • Ávila-Rejón CA; Pediatric Internal Medicine and Rheumatology Service, High Specialty Medical Unit, Hospital de Pediatría, Centro Médico Nacional de Occidente, IMSS, Guadalajara, Jalisco, Mexico.
  • Aguilar-Juárez PA; Genetics Department, Hospital de Alta Especialidad de Veracruz, Servicios de Salud de Veracruz, Xalapa, Veracruz, Mexico.
  • Espino-Pluma M; Neurology Service, Centro Médico Nacional 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado (ISSSTE), Mexico City, Mexico.
  • González-Santillanes CA; Internal Medicine Service, Clínica de Enfermedades Lisosomales, Hospital General de Zona 1, IMSS, Tlaxcala de Xicohténcatl, Tlaxcala, Mexico.
  • Martínez-Segovia RI; Rehabilitation Service, Hospital General Regional 1, IMSS, Culiacán, Sinaloa, Mexico.
  • Olmos-Morfin D; Internal Medicine Service, Hospital de Especialidades UMAE 25, Instituto Mexicano del Seguro Social (IMSS), Monterrey, Nuevo León, Mexico.
  • la Torre OP; Centro de Rehabilitación Infantil Teletón, Morelia, Michoacán, Mexico.
  • Solís-Sánchez I; Neurology Service, Centro Médico Nacional del Occidente, IMSS, Guadalajara, Jalisco, Mexico.
  • Espinosa MVM; Clínica de Enfermedades Neuromusculares, Centro Neurológico, Hospital Español de Veracruz, Veracruz, Veracruz, Mexico.
  • Villarroel-Cortés CE; Rheumatology Service, Hospital Civil Dr. Juan I. Menchaca, Guadalajara, Jalisco, Mexico.
  • Velarde-Félix JS; Genetics Service, Instituto Nacional de Pediatría, Mexico City, Mexico.
  • López-Valdez J; Universidad Autónoma de Sinaloa, Culiacán, Sinaloa, Mexico.
  • Olaiz-Urbina J; Genetics Service, Centenario Hospital Miguel Hidalgo, Secretaría de Salud, Aguascalientes, Aguascalientes, Mexico.
  • Ricárdez-Marcial E; Pediatrics Service, Hospital General de Zona 1, IMSS, La Paz, Baja California Sur, Mexico.
  • Vergara-Sánchez I; Genetics Service, Centro Médico Nacional La Raza, IMSS, Mexico City, Mexico.
  • Radillo-Díaz P; Pediatrics Neurology Service, Unidad Médica de Alta Especialidad, IMSS, Mérida, Yucatán, Mexico.
  • Kazakova E; Medical Department for Rare Diseases, Sanofi-Genzyme, Mexico City, Mexico.
  • De la Fuente-Cortez B; Medical Department for Rare Diseases, Sanofi-Genzyme, Mexico City, Mexico.
  • Del Carmen Marquez-Quiróz L; Genetics Service, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.
  • Torres-Octavo B; Genos Médica and Universidad Nacional Autónoma de México, Mexico City, Mexico.
  • Diaz-Martinez R; Laboratorio de Fibra Nerviosa Delgada, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Mol Genet Genomic Med ; 12(7): e2480, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38958145
ABSTRACT

BACKGROUND:

Pompe Disease (PD) is a metabolic myopathy caused by variants in the GAA gene, resulting in deficient enzymatic activity. We aimed to characterize the clinical features and related genetic variants in a series of Mexican patients.

METHODS:

We performed a retrospective study of clinical records of patients diagnosed with LOPD, IOPD or pseudodeficiency.

RESULTS:

Twenty-nine patients were included in the study, comprising these three forms. Overall, age of symptom onset was 0.1 to 43 years old. The most frequent variant identified was c.-32-13T>G, which was detected in 14 alleles. Among the 23 different variants identified in the GAA gene, 14 were classified as pathogenic, 5 were likely pathogenic, and 1 was a variant of uncertain significance. Two variants were inherited in cis arrangement and 2 were pseudodeficiency-related benign alleles. We identified two novel variants (c.1615 G>A and c.1076-20_1076-4delAAGTCGGCGTTGGCCTG).

CONCLUSION:

To the best of our knowledge, this series represent the largest phenotypic and genotypic characterization of patients with PD in Mexico. Patients within our series exhibited a combination of LOPD and IOPD associated variants, which may be related to genetic diversity within Mexican population. Further population-wide studies are required to better characterize the incidence of this disease in Mexican population.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glycogen Storage Disease Type II / Age of Onset / Alpha-Glucosidases / Mutation Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Mexico Language: En Journal: Mol Genet Genomic Med Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glycogen Storage Disease Type II / Age of Onset / Alpha-Glucosidases / Mutation Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Mexico Language: En Journal: Mol Genet Genomic Med Year: 2024 Document type: Article Affiliation country: Country of publication: